Effects of mutations in GrlA of topoisomerase IV from Staphylococcus aureus on quinolone and coumarin activity

被引:21
|
作者
Fournier, B
Hooper, DC
机构
[1] Harvard Univ, Div Infect Dis, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA
[2] Harvard Univ, Med Serv, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA
关键词
D O I
10.1128/AAC.42.8.2109
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The grlA genes of Staphylococcus aureus ISP794 (wild type), MT5224c4 (grlA [Phe-80]), MT5224c2 (grlA [Pro-116]), and MT111 (grlA [Glu-116]) were cloned in pSK950, a shuttle vector, and introduced into S, aureus strains derived from strain RN4220. The mutations at position 116 of GrlA (Ala-->Pro or Glu) caused an increase in the level of fluoroquinolone resistance and a decrease in the level of coumarin susceptibility, whereas the mutation at position 80 (Ser-->Phe) caused only an increase in the level of fluoroquinolone resistance. In multicopy alleles, both types of mutations were codominant for fluoroquinolone resistance, and mutations at position 116 were also codominant for coumarin resistance.
引用
收藏
页码:2109 / 2112
页数:4
相关论文
共 50 条
  • [41] The effects of macrolide and quinolone antibiotics in in methicillin-resistant Staphylococcus aureus biofilm growth
    Dasgupta, MK
    Shishido, H
    Salama, S
    Singh, R
    Larabie, M
    Micetich, RG
    ADVANCES IN PERITONEAL DIALYSIS/1997, VOL 13: SELECTED PAPERS FROM THE SEVENTEENTH ANNUAL CONFERENCE ON PERITONEAL DIALYSIS, DENVER, COLORADO, FEBRUARY 1997, 1997, 13 : 214 - 217
  • [42] Evaluation of a high-density oligonucleotide array for characterization of grlA, grlB, gyrA and gyrB mutations in fluoroquinolone resistant Staphylococcus aureus isolates
    Couzinet, S
    Yugueros, J
    Barras, C
    Visomblin, N
    Francois, P
    Lacroix, B
    Vernet, G
    Lew, D
    Troesch, A
    Schrenzel, J
    Jay, C
    JOURNAL OF MICROBIOLOGICAL METHODS, 2005, 60 (02) : 275 - 279
  • [43] DNA cleavage activities of Staphylococcus aureus gyrase and topoisomerase IV stimulated by quinolones and 2-pyridones
    Saiki, AYC
    Shen, LL
    Chen, CM
    Baranowski, J
    Lerner, CG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) : 1574 - 1577
  • [44] CLONING AND PRIMARY STRUCTURE OF STAPHYLOCOCCUS-AUREUS DNA TOPOISOMERASE-IV - A PRIMARY TARGET OF FLUOROQUINOLONES
    FERRERO, L
    CAMERON, B
    MANSE, B
    LAGNEAUX, D
    CROUZET, J
    FAMECHON, A
    BLANCHE, F
    MOLECULAR MICROBIOLOGY, 1994, 13 (04) : 641 - 653
  • [45] Topoisomerase mutations in fluoroquinolone-resistant and methicillin-susceptible and -resistant clinical isolates of Staphylococcus aureus
    Kaatz, GW
    Seo, SM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (01) : 197 - 198
  • [46] Novel, non-quinolone inhibitors of DNA gyrase and topoisomerase IV: Antibacterial activity and resistance mechanisms
    Mitton-Fry, Mark
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [47] Investigation of the antibacterial activity of new quinazoline derivatives against methicillin and quinolone resistant Staphylococcus aureus
    Patel, Amit B.
    JOURNAL OF CHEMICAL RESEARCH, 2020, 44 (5-6) : 315 - 321
  • [48] Assessment of the antibacterial activity of galangin against 4-quinolone resistant strains of Staphylococcus aureus
    Cushnie, TPT
    Lamb, A
    PHYTOMEDICINE, 2006, 13 (03) : 187 - 191
  • [49] Structural Insight into the Quinolone-DNA Cleavage Complex of Topoisomerase IV from Streptococcus Pneumoniae
    Sanderson, Mark R.
    Laponogov, Ivan
    Sohi, Maninder K.
    Veselkov, Dennis A.
    Pan, Xiao-Su
    Sawhney, Ritica
    Thompson, Andrew W.
    McAuley, Katherine
    Fisher, L. Mark
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2009, 65 : S41 - S42
  • [50] OCCURRENCE OF QUINOLONE RESISTANCE IN STAPHYLOCOCCUS-AUREUS FROM NOSOCOMIAL INFECTIONS - ASSOCIATION WITH MRSA
    WITTE, W
    GRIMM, H
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 294 - 295